536 results on '"Brown, Jubilee"'
Search Results
2. In silico design of novel multitarget small molecule inhibitors to treat PTEN-mutant endometrial carcinoma.
3. Sexual Harassment, Abuse, and Discrimination in Obstetrics and Gynecology
4. Improved Rates of Same-day Discharge in Patients Undergoing Surgery for Endometrial Cancer Following the COVID-19 Pandemic
5. The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes
6. Enhanced recovery after surgery (ERAS) protocol is associated with lower post-operative opioid use and a reduced office burden after minimally invasive surgery
7. Factors Associated with Same Day Discharge after Laparoscopic Surgery in Gynecologic Oncology
8. A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)
9. Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study
10. Comparison of Perioperative Outcomes between Minimally Invasive Sentinel Node Biopsy and Full Lymphadenectomy for Endometrial Cancer
11. Uterine carcinosarcomas: From pathology to practice
12. “Blooming in the Face of Adversity”
13. Pre-emptive Non-narcotic Pain Medication before Minimally Invasive Surgery in Gynecologic Oncology
14. Outcomes of Minimally Invasive versus Open Radical Hysterectomy for Early Stage Cervical Cancer Incorporating 2018 FIGO Staging
15. When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 Pandemic
16. Surgical and Clinical Reactivation for Elective Procedures during the COVID-19 Era: A Global Perspective
17. 977. Impact of Chlorhexidine (CHG) vaginal preparation compared to betadine on rates of Total abdominal Hysterectomy (TAH) Surgical Site Infections (SSI)
18. Supplementary Appendix 1 from Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
19. Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors
20. EP223/#840 Kazakhstan national experience: granulosa cell tumors of the ovary
21. EP224/#880 BRCA mutations in high grade serous ovarian cancer in Kazakhstan
22. Workplace Harassment and Discrimination in Gynecology: Results of the AAGL Member Survey
23. When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer
24. Phase III trials in ovarian cancer: The evolving landscape of front line therapy
25. Accuracy of Intraoperative Frozen Section Diagnosis of Borderline Ovarian Tumors by Hospital Type
26. Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer
27. Pemetrexed and Cisplatin for the Treatment of Advanced, Persistent, or Recurrent Carcinoma of the Cervix: A Limited Access Phase II Trial of the Gynecologic Oncology Group
28. Low-grade serous ovarian cancer: expert consensus report on the state of the science
29. A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer
30. Cancer of the Ovary, Uterus, and Cervix
31. Mucinous Carcinoma of the Ovary
32. Clinical trial methodology in rare gynecologic tumor research: Strategies for success
33. Early stage mucinous ovarian cancer: A review
34. Ovarian cancer screening with the Risk of Ovarian Cancer Algorithm (ROCA): Good, bad, or just expensive?
35. The Duty to Lead by Example
36. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry
37. Data from Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
38. Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
39. Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?
40. 15 years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage
41. Molecular variations in uterine carcinosarcomas identify therapeutic opportunities
42. Abstract 4480: Treatment of PTEN/PI3K co-mutated endometrial adenocarcinoma with multitarget small molecule inhibitors
43. Supplementary Figure 1 Legend from Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study
44. Supplementary Figure 1 from Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study
45. Opioid and benzodiazepine use in gynecologic oncology patients
46. Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma
47. Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer
48. Clinical Treatment of Adult Women with Ovarian Germ Cell Tumors
49. Too Much Skin in the Game? A Paradigm Shift in Our Understanding of Vulvovaginal Melanoma as a Distinct Tumor Type Compared to Cutaneous Melanoma
50. Complications of Electromechanical Morcellation Reported in the Manufacturer and User Facility Device Experience (MAUDE) Database
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.